The MAX-interacting transcription factor network
- 1 August 2006
- journal article
- review article
- Published by Elsevier BV in Seminars in Cancer Biology
- Vol. 16 (4), 265-274
- https://doi.org/10.1016/j.semcancer.2006.07.009
Abstract
The small bHLHZip protein MAX functions at the center of a transcription factor network that governs many aspects of cell behavior, including cell proliferation and tumorigenesis. MAX serves as a cofactor for DNA binding by the various members of this network, which include the MYC family of oncoproteins and a group of putative MYC antagonists that include MNT, MXD1-4 (formerly MAD1, MXI1, MAD3 and MAD4) and MGA. The many heterodimerization partners of MAX raises questions concerning the dynamics of MAX interactions and the functional consequences of the switching of Max partners. Here we review the activities of MAX, its interaction partners, and recent results showing that tissues lacking the MAX-interacting protein MNT are predisposed to tumor formation.This publication has 98 references indexed in Scilit:
- Mnt transcriptional repressor is functionally regulated during cell cycle progressionOncogene, 2005
- Evasion of the p53 tumour surveillance network by tumour-derived MYC mutantsNature, 2005
- c-Myc-regulated microRNAs modulate E2F1 expressionNature, 2005
- Whole-Genome Analysis Reveals a Strong Positional Bias of Conserved dMyc-Dependent E-BoxesMolecular and Cellular Biology, 2005
- Analysis of genomic targets reveals complex functions of MYCNature Reviews Cancer, 2004
- dMyc Transforms Cells into Super-CompetitorsCell, 2004
- Drosophila Myc Regulates Organ Size by Inducing Cell CompetitionCell, 2004
- Analysis of the max-binding protein MNT in human medulloblastomasInternational Journal of Cancer, 1999
- Point Mutations of the Mxil Gene are Rare in Prostate CancersThe Prostate, 1996
- Alternative Forms of Max as Enhancers or Suppressors of Myc-Ras CotransformationScience, 1992